Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07629869 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

COPD Flare-Up Clinic After Severe Exacerbations

Study acronym: FLARE-COPD
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened Show 5 more changesShow less
    • Eligibility criteria expanded, about 7 words
    • Secondary endpoints: details revised at 7 of 14 entries
    • Site details revised
    • Publications: details revised at 10 of 10 entries
    • Study description expanded, about 2 words
  2. Secondary endpoints: details revised at 1 of 14 entries
    • Study description expanded, about 1 word
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This prospective randomized controlled trial evaluates whether a specialized "COPD flare-up clinic service" improves outcomes in patients following an acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Patients presenting to the emergency department with AECOPD and discharged or hospitalized will be randomized 1:1 to either structured follow-up in a dedicated flare-up clinic or standard follow-up by scheduled telephone interviews. The researches hypothesize that structured follow-up in a specialized clinic will reduce recurrent exacerbations, optimize long-term COPD management, and improve patients' quality of life compared to standard care.
Trial Details
NCT Number NCT07629869
Lead Sponsor Tel-Aviv Sourasky Medical Center
Collaborators: AstraZeneca
Conditions
(from sponsor)		 COPD, COPD Exacerbation (AECOPD)
Related terms Pulmonary Disease, Chronic Obstructive
Enrollment 240 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov